Daniela Dwyer

1988 – 2022

Daniela’s Story

In April 2021, Daniela was diagnosed with an aggressive type of brain cancer, and just 11 months later, she tragically lost her battle.

Daniela was a beautiful partner, daughter and sister and became our inspiration for establishing The Daniela Dwyer Foundation. Her struggle with brain cancer is our motivation for wanting to make a meaningful change in the diagnosis and treatment of all brain cancer sufferers.

Our Mission

Inspired by Daniela’s legacy, our mission is to transform the future of brain cancer care by funding the innovations that matter most—from groundbreaking research to clinician education and equitable patient access—ensuring life-saving advances reach the people who need them most.

About Brain Cancer

Little has changed in the last three decades in the way brain cancer is treated, and consequently mortality rates remain high. We want to change that.

High mortality rate

Brain cancer kills more Australians under 40 than any other cancer and kills more children than any other disease.

Lack of research

Brain cancer survival rates have only increased by 1% in the last 30 years.

Lack of funding

Brain cancer receives less than 5% of Federal Government cancer research funding.

From Laboratory to Lifesaving

The Daniela Dwyer Fellowship is funding critical advancements in the early detection and intervention of aggressive brain cancers.
To date, DDF has awarded $250,000 in research grants — directly supporting groundbreaking brain cancer research and bringing new diagnostic and treatment initiatives closer to reality for patients and families.

Read about the Daniela Dwyer Fellowship…

What Your Donation Supports

  • Funding educational grants to Australian clinicians to access specialised training and education, helping bring world-leading brain cancer diagnostic technologies into clinical practice.
  • Providing compassionate access funding for patients so they can access this innovative diagnostic testing, regardless of their financial circumstances.
  • Continuing to fund pioneering research into drug toxicity to improve treatment selection, reduce harmful side effects, and deliver safer, more personalised therapies.

Our Partners

Get in touch

Do you have a question about what we do? For any enquiries please don’t hesitate to contact us.